Report Detail
Global (United States, European Union and China) Friedreich Ataxia Drug Market Research Report 2019-2025
- RnM3370617 |
- 01 May, 2019 |
- Global |
- 120 Pages |
- QYResearch |
- Pharma & Healthcare
In 2019, the market size of Friedreich Ataxia Drug is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Friedreich Ataxia Drug.
This report studies the global market size of Friedreich Ataxia Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Friedreich Ataxia Drug sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Adverum Biotechnologies Inc
BioMarin Pharmaceutical Inc.
Biovista Inc.
Cardero Therapeutics Inc
Catabasis Pharmaceuticals, Inc.
Forward Pharma A/S
Ixchel Pharma LLC
Pfizer Inc
ProQR Therapeutics NV
RaNA Therapeutics Inc
Reata Pharmaceuticals Inc
Retrotope Inc
Shire Plc
STATegics Inc
Voyager Therapeutics Inc
Market Segment by Product Type
ADVM-063
AGIL-FA
BHV-4157
BVA-202
Others
Market Segment by Application
Clinic
Hospital
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Friedreich Ataxia Drug status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Friedreich Ataxia Drug manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Friedreich Ataxia Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Friedreich Ataxia Drug Market Size Growth Rate by Type (2019-2025)
- 1.3.2 ADVM-063
- 1.3.3 AGIL-FA
- 1.3.4 BHV-4157
- 1.3.5 BVA-202
- 1.3.6 Others
- 1.4 Market Segment by Application
- 1.4.1 Global Friedreich Ataxia Drug Market Share by Application (2019-2025)
- 1.4.2 Clinic
- 1.4.3 Hospital
- 1.4.4 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Friedreich Ataxia Drug Market Size
- 2.1.1 Global Friedreich Ataxia Drug Revenue 2014-2025
- 2.1.2 Global Friedreich Ataxia Drug Sales 2014-2025
- 2.2 Friedreich Ataxia Drug Growth Rate by Regions
- 2.2.1 Global Friedreich Ataxia Drug Sales by Regions 2014-2019
- 2.2.2 Global Friedreich Ataxia Drug Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Friedreich Ataxia Drug Sales by Manufacturers
- 3.1.1 Friedreich Ataxia Drug Sales by Manufacturers 2014-2019
- 3.1.2 Friedreich Ataxia Drug Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Friedreich Ataxia Drug Revenue by Manufacturers (2014-2019)
- 3.2.2 Friedreich Ataxia Drug Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Friedreich Ataxia Drug Market Concentration Ratio (CR5 and HHI)
- 3.3 Friedreich Ataxia Drug Price by Manufacturers
- 3.4 Key Manufacturers Friedreich Ataxia Drug Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Friedreich Ataxia Drug Market
- 3.6 Key Manufacturers Friedreich Ataxia Drug Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 ADVM-063 Sales and Revenue (2014-2019)
- 4.1.2 AGIL-FA Sales and Revenue (2014-2019)
- 4.1.3 BHV-4157 Sales and Revenue (2014-2019)
- 4.1.4 BVA-202 Sales and Revenue (2014-2019)
- 4.1.5 Others Sales and Revenue (2014-2019)
- 4.2 Global Friedreich Ataxia Drug Sales Market Share by Type
- 4.3 Global Friedreich Ataxia Drug Revenue Market Share by Type
- 4.4 Friedreich Ataxia Drug Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Friedreich Ataxia Drug Sales by Application
6 United States
- 6.1 United States Friedreich Ataxia Drug Breakdown Data by Company
- 6.2 United States Friedreich Ataxia Drug Breakdown Data by Type
- 6.3 United States Friedreich Ataxia Drug Breakdown Data by Application
7 European Union
- 7.1 European Union Friedreich Ataxia Drug Breakdown Data by Company
- 7.2 European Union Friedreich Ataxia Drug Breakdown Data by Type
- 7.3 European Union Friedreich Ataxia Drug Breakdown Data by Application
8 China
- 8.1 China Friedreich Ataxia Drug Breakdown Data by Company
- 8.2 China Friedreich Ataxia Drug Breakdown Data by Type
- 8.3 China Friedreich Ataxia Drug Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Friedreich Ataxia Drug Breakdown Data by Company
- 9.2 Rest of World Friedreich Ataxia Drug Breakdown Data by Type
- 9.3 Rest of World Friedreich Ataxia Drug Breakdown Data by Application
- 9.4 Rest of World Friedreich Ataxia Drug Breakdown Data by Countries
- 9.4.1 Rest of World Friedreich Ataxia Drug Sales by Countries
- 9.4.2 Rest of World Friedreich Ataxia Drug Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Adverum Biotechnologies Inc
- 10.1.1 Adverum Biotechnologies Inc Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Friedreich Ataxia Drug
- 10.1.4 Friedreich Ataxia Drug Product Introduction
- 10.1.5 Adverum Biotechnologies Inc Recent Development
- 10.2 BioMarin Pharmaceutical Inc.
- 10.2.1 BioMarin Pharmaceutical Inc. Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Friedreich Ataxia Drug
- 10.2.4 Friedreich Ataxia Drug Product Introduction
- 10.2.5 BioMarin Pharmaceutical Inc. Recent Development
- 10.3 Biovista Inc.
- 10.3.1 Biovista Inc. Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Friedreich Ataxia Drug
- 10.3.4 Friedreich Ataxia Drug Product Introduction
- 10.3.5 Biovista Inc. Recent Development
- 10.4 Cardero Therapeutics Inc
- 10.4.1 Cardero Therapeutics Inc Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Friedreich Ataxia Drug
- 10.4.4 Friedreich Ataxia Drug Product Introduction
- 10.4.5 Cardero Therapeutics Inc Recent Development
- 10.5 Catabasis Pharmaceuticals, Inc.
- 10.5.1 Catabasis Pharmaceuticals, Inc. Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Friedreich Ataxia Drug
- 10.5.4 Friedreich Ataxia Drug Product Introduction
- 10.5.5 Catabasis Pharmaceuticals, Inc. Recent Development
- 10.6 Forward Pharma A/S
- 10.6.1 Forward Pharma A/S Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Friedreich Ataxia Drug
- 10.6.4 Friedreich Ataxia Drug Product Introduction
- 10.6.5 Forward Pharma A/S Recent Development
- 10.7 Ixchel Pharma LLC
- 10.7.1 Ixchel Pharma LLC Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Friedreich Ataxia Drug
- 10.7.4 Friedreich Ataxia Drug Product Introduction
- 10.7.5 Ixchel Pharma LLC Recent Development
- 10.8 Pfizer Inc
- 10.8.1 Pfizer Inc Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Friedreich Ataxia Drug
- 10.8.4 Friedreich Ataxia Drug Product Introduction
- 10.8.5 Pfizer Inc Recent Development
- 10.9 ProQR Therapeutics NV
- 10.9.1 ProQR Therapeutics NV Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Friedreich Ataxia Drug
- 10.9.4 Friedreich Ataxia Drug Product Introduction
- 10.9.5 ProQR Therapeutics NV Recent Development
- 10.10 RaNA Therapeutics Inc
- 10.10.1 RaNA Therapeutics Inc Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Friedreich Ataxia Drug
- 10.10.4 Friedreich Ataxia Drug Product Introduction
- 10.10.5 RaNA Therapeutics Inc Recent Development
- 10.11 Reata Pharmaceuticals Inc
- 10.12 Retrotope Inc
- 10.13 Shire Plc
- 10.14 STATegics Inc
- 10.15 Voyager Therapeutics Inc
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Friedreich Ataxia Drug Sales Channels
- 11.2.2 Friedreich Ataxia Drug Distributors
- 11.3 Friedreich Ataxia Drug Customers
12 Market Forecast
- 12.1 Global Friedreich Ataxia Drug Sales and Revenue Forecast 2019-2025
- 12.2 Global Friedreich Ataxia Drug Sales Forecast by Type
- 12.3 Global Friedreich Ataxia Drug Sales Forecast by Application
- 12.4 Friedreich Ataxia Drug Forecast by Regions
- 12.4.1 Global Friedreich Ataxia Drug Sales Forecast by Regions 2019-2025
- 12.4.2 Global Friedreich Ataxia Drug Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Friedreich Ataxia Drug . Industry analysis & Market Report on Friedreich Ataxia Drug is a syndicated market report, published as Global (United States, European Union and China) Friedreich Ataxia Drug Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Friedreich Ataxia Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
